APR 21, 2020 6:28 AM PDT

Skin Deep: Handheld Device Sees the Earliest Signs of Cancer

WRITTEN BY: Tara Fernandez

 

Researchers have developed a handheld device that can image structures under the skin at resolutions 100 times greater than that of X-Rays, computed tomography (CT) and Magnetic Resonance Imaging (MRI).

The device was designed to be portable and easy to use, allowing healthcare personnel to image internal organs directly at a clinic or the patient’s bedside — avoiding the long waits and costs of specialized diagnostic facilities.

This new imaging technology is so sensitive that it can detect some of the earliest cellular abnormalities linked to cancer. This is particularly important for spotting tumors originating in the epithelium, a thin layer of tissue lining organs such as the colon, stomach and skin. Current imaging technologies often fall short when it comes to imaging epithelial tissues as they are unable to reach tissue depths of even a single millimetre.

Known as micro optical coherence tomography, or OCT, this new device relies on the near-infrared spectrum of light that penetrates the human body harmlessly. The device accurately measures the time taken for the emitted light to return after bouncing off internal tissues, allowing it to construct an image of the 3-dimensional structures below the skin.

 

 

Six years in the making, this research was the fruit of a collaborative effort between imaging scientists at Nanyang Technological University, Singapore, Harvard Medical School and the University of Alabama.

Lead researcher, Professor Liu Linbo, said, “Our device is a fraction of the size of existing machines and produces clear, high-resolution images in real-time. It uses light to harmlessly penetrate the skin, and it does not involve specialised lead-shielded X-ray equipment or MRI scanners. It is small enough to be handheld, so images could be captured by the bedside.”

A prototype of the device was trialled at the Renmin Hospital of Wuhan University to validate its use in detecting colon polyps — small clumps of cells that form in the lining of the colon or rectum which can progress into cancer. Colonoscopies are the most sensitive test for colorectal polyps, but are invasive and have to be done under sedation.

When put to the test, the device was able to assess whether polyps were malignant or benign with 95 percent accuracy. Commercialization of this technology could pick up cancerous changes much earlier, vastly improving patient outcomes.

 

Source: Nanyang Technological University.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 18, 2020
Clinical & Molecular DX
Open Your Heart to the World's Smallest Diagnostic Probe
SEP 18, 2020
Open Your Heart to the World's Smallest Diagnostic Probe
Certain health conditions require doctors to be able to observe tissues and organs in order to tell what’s wrong. ...
OCT 22, 2020
Cardiology
Using Liposomes to Deliver Repair Packages to the Heart
OCT 22, 2020
Using Liposomes to Deliver Repair Packages to the Heart
The secret to any successful drug is not just its ability to treat a disease but its ability to target the disease exclu ...
OCT 23, 2020
Clinical & Molecular DX
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
OCT 23, 2020
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally, resulting in the loss of nearly 18 million lives each yea ...
OCT 24, 2020
Clinical & Molecular DX
Software Flags Elevated Cerebral Palsy Risk in Premies
OCT 24, 2020
Software Flags Elevated Cerebral Palsy Risk in Premies
Diagnostic imaging scientists have developed a software tool for predicting the future onset of cerebral palsy in babies ...
DEC 02, 2020
Clinical & Molecular DX
Digital Platform Watches for a Silent COVID Killer
DEC 02, 2020
Digital Platform Watches for a Silent COVID Killer
 
JAN 07, 2021
Clinical & Molecular DX
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
JAN 07, 2021
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
Cardiovascular disease is the leading cause of death worldwide, taking nearly 18 million lives every year. Of these card ...
Loading Comments...